
Christopher M. Babic
Supervisory Patent Examiner (ID: 16842, Phone: (571)272-8507 , Office: P/1633 )
| Most Active Art Unit | 1637 |
| Art Unit(s) | 1635, 1633, 1674, 1637 |
| Total Applications | 603 |
| Issued Applications | 296 |
| Pending Applications | 60 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20578764
[patent_doc_number] => 12571007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Extraction of antimethanogenic compounds
[patent_app_type] => utility
[patent_app_number] => 19/061532
[patent_app_country] => US
[patent_app_date] => 2025-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15377
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19061532
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/061532 | Extraction of antimethanogenic compounds | Feb 23, 2025 | Issued |
Array
(
[id] => 20421257
[patent_doc_number] => 20250383342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-18
[patent_title] => Epigen AU/11: A NATURAL MATRIX FOR RESTORING HOMEOSTASIS IN CANCER CELL-INFILTRATED TISSUE
[patent_app_type] => utility
[patent_app_number] => 19/044249
[patent_app_country] => US
[patent_app_date] => 2025-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19044249
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/044249 | Epigen AU/11: a natural matrix for restoring homeostasis in cancer cell-infiltrated tissue | Feb 2, 2025 | Issued |
Array
(
[id] => 19883090
[patent_doc_number] => 12268774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Compositions and methods for in utero delivery
[patent_app_type] => utility
[patent_app_number] => 18/397091
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 22486
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397091 | Compositions and methods for in utero delivery | Dec 26, 2023 | Issued |
Array
(
[id] => 20578769
[patent_doc_number] => 12571012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Polyhydroxyalkanoic acid compositions and methods for generating same
[patent_app_type] => utility
[patent_app_number] => 18/534335
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3460
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18534335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/534335 | Polyhydroxyalkanoic acid compositions and methods for generating same | Dec 7, 2023 | Issued |
Array
(
[id] => 20579565
[patent_doc_number] => 12571812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Parallel cell processing method and facility
[patent_app_type] => utility
[patent_app_number] => 18/531157
[patent_app_country] => US
[patent_app_date] => 2023-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3242
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18531157
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/531157 | Parallel cell processing method and facility | Dec 5, 2023 | Issued |
Array
(
[id] => 19629709
[patent_doc_number] => 20240408158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => APPLICATION OF ANTARCTIC RED PIGMENT IN PREPARATION OF DRUGS FOR TREATMENT AND PREVENTION OF HYPERURICEM
[patent_app_type] => utility
[patent_app_number] => 18/501227
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501227
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501227 | APPLICATION OF ANTARCTIC RED PIGMENT IN PREPARATION OF DRUGS FOR TREATMENT AND PREVENTION OF HYPERURICEM | Nov 2, 2023 | Abandoned |
Array
(
[id] => 19083347
[patent_doc_number] => 20240110148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => MATERIALS AND METHODS FOR ALGAL INOCULATION TO EFFECT DIRECT CAPTURE OF CARBON DIOXIDE FROM AIR
[patent_app_type] => utility
[patent_app_number] => 18/376827
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376827 | Materials and methods for algal inoculation to effect direct capture of carbon dioxide from air | Oct 3, 2023 | Issued |
Array
(
[id] => 20577569
[patent_doc_number] => 12569808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Carbon capture by algal inoculation of ocean ice and/or sea ice
[patent_app_type] => utility
[patent_app_number] => 18/376832
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2354
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376832
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376832 | Carbon capture by algal inoculation of ocean ice and/or sea ice | Oct 3, 2023 | Issued |
Array
(
[id] => 18784644
[patent_doc_number] => 20230372233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => COMPOSITION AND METHODS FOR HAIR REGROWTH
[patent_app_type] => utility
[patent_app_number] => 18/321701
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321701 | COMPOSITION AND METHODS FOR HAIR REGROWTH | May 21, 2023 | Abandoned |
Array
(
[id] => 18537518
[patent_doc_number] => 20230242615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => FUSION POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/064054
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/064054 | FUSION POLYPEPTIDE | Dec 8, 2022 | Abandoned |
Array
(
[id] => 19510417
[patent_doc_number] => 20240342103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/251185
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251185
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251185 | NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF | Nov 24, 2022 | Pending |
Array
(
[id] => 19572183
[patent_doc_number] => 20240376475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/554692
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554692 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) PROTEIN | Sep 21, 2022 | Pending |
Array
(
[id] => 18271490
[patent_doc_number] => 20230092732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => NUCLEIC ACID CONSTRUCT SET, KIT, DETECTION METHOD AND METHOD FOR PREDICTING DRUG EFFECT
[patent_app_type] => utility
[patent_app_number] => 17/930890
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930890 | Nucleic acid construct set, kit, detection method and method for predicting drug effect | Sep 8, 2022 | Issued |
Array
(
[id] => 18612755
[patent_doc_number] => 20230279490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => DEPLETION PROBES
[patent_app_type] => utility
[patent_app_number] => 17/881335
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881335 | DEPLETION PROBES | Aug 3, 2022 | Pending |
Array
(
[id] => 18310189
[patent_doc_number] => 20230114089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHOD FOR INDUCING DOPAMINERGIC NEURON PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/824603
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824603
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824603 | Method for inducing dopaminergic neuron progenitor cells | May 24, 2022 | Issued |
Array
(
[id] => 18643450
[patent_doc_number] => 11767510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/733875
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 113
[patent_no_of_words] => 72942
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733875 | Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof | Apr 28, 2022 | Issued |
Array
(
[id] => 18274832
[patent_doc_number] => 11613766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Adeno-associated virus variant capsids and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/718870
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 34
[patent_no_of_words] => 36506
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17718870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/718870 | Adeno-associated virus variant capsids and methods of use thereof | Apr 11, 2022 | Issued |
Array
(
[id] => 19601418
[patent_doc_number] => 20240392298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => BIOLOGICALLY STABLE XNAZYME THAT EFFICIENTLY SILENCES GENE EXPRESSION IN CELLS
[patent_app_type] => utility
[patent_app_number] => 18/260166
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260166
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260166 | BIOLOGICALLY STABLE XNAZYME THAT EFFICIENTLY SILENCES GENE EXPRESSION IN CELLS | Dec 22, 2021 | Pending |
Array
(
[id] => 18675573
[patent_doc_number] => 20230313186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => TROPHIN GENOME EDITING FOR TREATING DUCHENNE MUSCULAR DYSTROPHY (DMD)
[patent_app_type] => utility
[patent_app_number] => 18/005612
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005612 | TROPHIN GENOME EDITING FOR TREATING DUCHENNE MUSCULAR DYSTROPHY (DMD) | Jul 25, 2021 | Pending |
Array
(
[id] => 18692993
[patent_doc_number] => 20230323366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 18/014977
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014977
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014977 | COMPOUNDS FOR USE IN THE TREATMENT OF EPILEPSY | Jul 8, 2021 | Pending |